Technetium (99mTc) votumumab
From Wikipedia, the free encyclopedia
|Target||tumor antigen CTAA16.88|
|Legal status||not marketed|
|(what is this?)|
Technetium (99mTc) votumumab (trade name HumaSPECT) is a human monoclonal antibody labelled with the radionuclide technetium-99m. It was developed for the detection of colorectal tumors, but has never been marketed.
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|
|This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.|